| Literature DB >> 23926460 |
Divya T Koura1, Amelia A Langston.
Abstract
Multiple myeloma (MM) is the second most common hematologic malignancy in the United States, after non-Hodgkin lymphoma. Family pedigree analyses of high-risk families, case-control studies and racial disparities in disease incidence all point to a potential inherited predisposition to MM. Genome-wide association studies (GWASs) have identified susceptibility loci in a number of cancers and such studies are currently underway in MM. To date, GWASs in MM have identified several potential regions of interest for further study on chromosomes 3p22, 7p15.3, 8q24 and 2p23.3. In addition, several targets of paraproteins (so called 'paratargs') in MM have been identified. Hyperphosphorylation of the paratarg protein, which is inherited in an autosomal dominant manner, appears a common mechanism underlying the antigenicity of these proteins. One particular protein, hyperphosphorylated paratarg-7 (pP-7) is a common target in persons with myeloma and has also been identified in affected members of several high-risk MM families. It appears that the frequency of pP-7 as an antigenic target may be particularly high in African American patients with MM, which could be part of the explanation for observed racial disparities in the incidence of MM. In this review we focus on available data in the area of inherited predisposition to MM, and highlight future research directions.Entities:
Keywords: Waldenström macroglobulinemia/genetics; autoantigens/genetics; genetic predisposition to disease; monoclonal gammopathy of undetermined significance/genetics; multiple myeloma/epidemiology; multiple myeloma/genetics; paraproteins/genetics; phosphorylation/physiology; risk factors
Year: 2013 PMID: 23926460 PMCID: PMC3734900 DOI: 10.1177/2040620713485375
Source DB: PubMed Journal: Ther Adv Hematol ISSN: 2040-6207